KMVAX vs. GENIX

Last updated Jun 4, 2026

KMVAX (Kirr Marbach Partners Value Fund) and GENIX (Gotham Enhanced Return Fund) are both Mid Cap Blend Equities funds. Over the past 10 years, KMVAX returned 11.39%/yr vs 13.94%/yr for GENIX. Their correlation of 0.84 suggests significant overlap in exposure. KMVAX charges 1.45%/yr vs 1.50%/yr for GENIX.

Performance

KMVAX vs. GENIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Kirr Marbach Partners Value Fund (KMVAX) and Gotham Enhanced Return Fund (GENIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with KMVAX having a 14.03% return and GENIX slightly lower at 13.91%. Over the past 10 years, KMVAX has underperformed GENIX with an annualized return of 11.39%, while GENIX has yielded a comparatively higher 13.94% annualized return.

KMVAX

• 1D: 0.48%
• 1M: 1.04%
• YTD: 14.03%
• 6M: 11.46%
• 1Y: 22.13%
• 3Y*: 22.39%
• 5Y*: 13.23%
• 10Y*: 11.39%

GENIX

• 1D: -0.24%
• 1M: 6.37%
• YTD: 13.91%
• 6M: 14.63%
• 1Y: 30.71%
• 3Y*: 26.90%
• 5Y*: 17.80%
• 10Y*: 13.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

KMVAX vs. GENIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
KMVAX Kirr Marbach Partners Value Fund	14.03%	14.44%	27.82%	20.42%	-16.01%	28.83%	2.96%	27.03%	-19.72%	16.12%
GENIX Gotham Enhanced Return Fund	13.91%	21.16%	27.31%	25.26%	-12.02%	39.66%	-8.21%	21.54%	-5.97%	18.21%

Correlation

The correlation between KMVAX and GENIX is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.77
Correlation (3Y) Calculated over the trailing 3-year period	0.81
Correlation (5Y) Calculated over the trailing 5-year period	0.86
Correlation (10Y) Calculated over the trailing 10-year period	0.84
Correlation (All Time) Calculated using the full available price history since Jan 3, 2014	0.84

The correlation between KMVAX and GENIX has been stable across timeframes, ranging from 0.77 to 0.86 - a consistent structural relationship.

Return for Risk

KMVAX vs. GENIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KMVAX

KMVAX Risk / Return Rank: 29
KMVAX Sharpe Ratio Rank: 28
KMVAX Sortino Ratio Rank: 27
KMVAX Omega Ratio Rank: 26
KMVAX Calmar Ratio Rank: 37
KMVAX Martin Ratio Rank: 25

GENIX

GENIX Risk / Return Rank: 83
GENIX Sharpe Ratio Rank: 82
GENIX Sortino Ratio Rank: 77
GENIX Omega Ratio Rank: 69
GENIX Calmar Ratio Rank: 92
GENIX Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KMVAX vs. GENIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Kirr Marbach Partners Value Fund (KMVAX) and Gotham Enhanced Return Fund (GENIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	KMVAX	GENIX	Difference
Sharpe ratio Return per unit of total volatility	1.51	2.65	-1.14
Sortino ratio Return per unit of downside risk	2.18	3.68	-1.50
Omega ratio Gain probability vs. loss probability	1.27	1.46	-0.20
Calmar ratio Return relative to maximum drawdown	2.30	4.95	-2.65
Martin ratio Return relative to average drawdown	6.27	21.97	-15.69
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

KMVAX vs. GENIX - Sharpe Ratio Comparison

The current KMVAX Sharpe Ratio is 1.51, which is lower than the GENIX Sharpe Ratio of 2.65. The chart below compares the historical Sharpe Ratios of KMVAX and GENIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	KMVAX	GENIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.51	2.65	-1.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	1.04	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.57	0.76	-0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.66	-0.24

Drawdowns

KMVAX vs. GENIX - Drawdown Comparison

The maximum KMVAX drawdown since its inception was -65.81%, which is greater than GENIX's maximum drawdown of -39.35%. Use the drawdown chart below to compare losses from any high point for KMVAX and GENIX.

Drawdown Indicators

	KMVAX	GENIX	Difference
Max Drawdown Largest peak-to-trough decline	-65.81%	-39.35%	-26.46%
Max Drawdown (1Y) Largest decline over 1 year	-10.22%	-6.44%	-3.78%
Max Drawdown (3Y) Largest decline over 3 years	-21.26%	-19.20%	-2.06%
Max Drawdown (5Y) Largest decline over 5 years	-24.84%	-20.74%	-4.10%
Max Drawdown (10Y) Largest decline over 10 years	-45.41%	-39.35%	-6.06%
Current Drawdown Current decline from peak	-1.04%	-0.24%	-0.80%
Average Drawdown Average peak-to-trough decline	-9.99%	-5.65%	-4.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.73%	1.44%	+2.29%

Volatility

KMVAX vs. GENIX - Volatility Comparison

Kirr Marbach Partners Value Fund (KMVAX) has a higher volatility of 4.16% compared to Gotham Enhanced Return Fund (GENIX) at 2.62%. This indicates that KMVAX's price experiences larger fluctuations and is considered to be riskier than GENIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	KMVAX	GENIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.16%	2.62%	+1.54%
Volatility (6M) Calculated over the trailing 6-month period	11.82%	8.90%	+2.92%
Volatility (1Y) Calculated over the trailing 1-year period	15.56%	12.01%	+3.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.39%	17.19%	+1.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.14%	18.53%	+1.61%

KMVAX vs. GENIX - Expense Ratio Comparison

KMVAX has a 1.45% expense ratio, which is lower than GENIX's 1.50% expense ratio.

Dividends

KMVAX vs. GENIX - Dividend Comparison

KMVAX's dividend yield for the trailing twelve months is around 4.64%, more than GENIX's 1.82% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
GENIX Gotham Enhanced Return Fund	1.82%	2.07%	19.28%	9.82%	8.02%	19.31%	0.14%	32.49%	9.60%	0.97%	0.00%	1.85%
KMVAX Kirr Marbach Partners Value Fund	4.64%	5.30%	7.58%	3.35%	3.57%	3.72%	1.35%	2.11%	9.38%	6.87%	5.64%	0.34%

Frequently Asked Questions

Can I hold both KMVAX and GENIX in my portfolio?

KMVAX and GENIX have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, KMVAX or GENIX?

KMVAX has higher volatility (4.16%) compared to GENIX (2.62%). In terms of maximum drawdown, KMVAX dropped -65.81% vs GENIX's -39.35%.

Which has better risk-adjusted returns?

GENIX currently has the higher Sharpe Ratio (2.65 vs 1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.